Literature DB >> 26288101

Effects of intradialytic exercise on systemic cytokine in patients with chronic kidney disease.

Alessandra Peres1,2, Daniela Lazzarotto Perotto1, Gilson Pires Dorneles1,2, Maria Isabel Severini Fuhro1, Mariane Borba Monteiro1,3.   

Abstract

BACKGROUND: Immunological dysfunctions and a pro-inflammatory environment are associated with higher risk of cardiovascular diseases in chronic kidney disease (CKD). Physical exercise can be an important anti-inflammatory strategy, but the effects in CKD remain poorly investigated.
OBJECTIVE: Evaluate the acute inflammatory response to intradialytic exercise in the peripheral blood of individuals with CKD.
METHODS: Nine patients, of both genders, with CKD and allocated in the ambulatory of hemodialysis of Hospital Ernesto Dornelles (Brazil), performed two sessions of hemodialysis (HD) in random form: aerobic intradialytic exercise sessions (EX, 20 min of moderate exercise in cycle-ergometer) and a control hemodialysis session (CON). Peripheral blood collection was made at the baseline, during and immediately after HD to evaluate the cytokine profile: interleukin-6, interleukin-10 (IL-10), interleukin-17a (IL-17a), interferon-gamma (INF-γ) and tumoral necrosis factor-alpha (TNF-α).
RESULTS: INF-γ decreased during HD when compared with the pre moment in both sessions, while an increase in post HD was only found in the CON session. IL-17 was higher in post when compared with during HD in both sessions. In addition to the time effect, IL-10 presented a time × group interaction and the relative changes were significantly higher in EX when compared with the CON session. The relative changes in TNF-α tended to be higher in CON when compared with EX immediately post HD session.
CONCLUSIONS: These data indicate that 20 min of intradialytic exercise have modest effect in systemic inflammation. However, the significant increase in IL-10 may indicate an immunoregulatory effect of physical exercise.

Entities:  

Keywords:  Chronic kidney disease; hemodialysis; inflammation; peripheral blood; physical exercise

Mesh:

Substances:

Year:  2015        PMID: 26288101     DOI: 10.3109/0886022X.2015.1074473

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  5 in total

1.  Acute exercise during hemodialysis prevents the decrease in natural killer cells in patients with chronic kidney disease: a pilot study.

Authors:  Maria Isabel Fuhro; Gilson P Dorneles; Francini P Andrade; Pedro R T Romão; Alessandra Peres; Mariane B Monteiro
Journal:  Int Urol Nephrol       Date:  2017-11-13       Impact factor: 2.370

2.  Melatonin ingestion before intradialytic exercise improves immune responses in hemodialysis patients.

Authors:  Houssem Marzougui; Omar Hammouda; Imen Ben Dhia; Rami Maaloul; Ikram Agrebi; Hanen Chaker; Khaoula Kammoun; Mohamed Ben Hmida; Fatma Ayadi; Choumous Kallel; Tarak Driss; Mouna Turki; Hatem Masmoudi; Hend Hachicha
Journal:  Int Urol Nephrol       Date:  2020-09-23       Impact factor: 2.370

Review 3.  The impact of exercise on physical function, cardiovascular outcomes and quality of life in chronic kidney disease patients: a systematic review.

Authors:  Baris Afsar; Dimitrie Siriopol; Gamze Aslan; Ozgur C Eren; Tuncay Dagel; Ugur Kilic; Asiye Kanbay; Alexandru Burlacu; Adrian Covic; Mehmet Kanbay
Journal:  Int Urol Nephrol       Date:  2018-01-17       Impact factor: 2.370

4.  Intradialytic cycling does not exacerbate microparticles or circulating markers of systemic inflammation in haemodialysis patients.

Authors:  Patrick J Highton; Daniel S March; Darren R Churchward; Charlotte E Grantham; Hannah M L Young; Matthew P M Graham-Brown; Seila Estruel; Naomi Martin; Nigel J Brunskill; Alice C Smith; James O Burton; Nicolette C Bishop
Journal:  Eur J Appl Physiol       Date:  2021-12-02       Impact factor: 3.078

Review 5.  Effect of Exercise on Inflammation in Hemodialysis Patients: A Systematic Review.

Authors:  Erika Meléndez Oliva; Jorge H Villafañe; Jose Luis Alonso Pérez; Alexandra Alonso Sal; Guillermo Molinero Carlier; Andrés Quevedo García; Silvia Turroni; Oliver Martínez-Pozas; Norberto Valcárcel Izquierdo; Eleuterio A Sánchez Romero
Journal:  J Pers Med       Date:  2022-07-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.